Last updated: 2026-09-04 22:54:40. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
Johnson & Johnson (JNJ) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NYSE. The stock is currently priced at $275,20, with a market capitalisation of $663,23B and a P/E ratio of 31,90. Over the past 52 weeks, its price has ranged from $173,33 to $281,07. This page covers its latest market performance, valuation, price trends and company information.
$663,23B | |
$275,13 | |
$281,07 | |
$46,25 | |
$278,43 | |
2,77M | |
-- | |
31,90 | |
$281,07 | |
$173,33 | |
1,88% | |
-- |
Johnson & Johnson (JNJ) is trading at $275,75 in after-hours trading as of 2026-09-04 22:52:00, down 0,96% ($2,68) from the regular-session close of $278,43.
After-hours trading shows how investors are pricing JNJ after the regular session closes. The current after-hours price is below the regular-session close, indicating cautious after-hours sentiment.
Over the past seven days, Johnson & Johnson (JNJ) moved from $267,13 to $275,20, representing a gain of 3,02% ($8,08).
The stock traded between $275,03 and $278,51 during the period. The latest price is near the lower end of the 7-day range, indicating moderate upward.
The average daily volume was 6,46 million shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 94,6%
JNJ is currently trading at $275,20, placing it 94,6% of the way from its 52-week low of $173,33 to its 52-week high of $281,07. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 140800 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of Johnson & Johnson (JNJ) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.